Annual European CDC report says infectious diseases, drug resistance are concerns

"Europe's health is suffering, with around 80,000 cases of tuberculosis infection a year and serious problems with measles, HIV and threats from 'superbug' infections, an annual health report" from the European Centre for Disease Prevention and Control (ECDC) said Thursday, Reuters reports. The report said infectious diseases and antibiotic resistance, especially multi-drug resistance, are major concerns, according to the news service. The "report also identified several emergent diseases in Europe it said might pose a risk to public health," including West Nile virus, malaria, dengue fever and chikungunya, Reuters notes.

In the forward of the report, ECDC Director Marc Sprenger writes, "The biggest threat we face is complacency about infectious diseases. The attitude that the battle against infectious diseases has been won must be continuously challenged," according to Reuters. "The 2011 report is based on data from 2009 and 2010 ... but officials said the picture it paints is one that has changed little. If anything, things appear to have gotten worse," the news agency writes (Kelland, 11/10).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition